There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arbutus Biopharma (ABUS – Research Report), Karuna Therapeutics (KRTX – Research Report) and Arcutis Biotherapeutics (ARQT – Research Report) with bullish sentiments.
Arbutus Biopharma (ABUS)
In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on Arbutus Biopharma, with a price target of $9.00. The company’s shares closed last Monday at $2.68, close to its 52-week low of $1.93.
According to TipRanks.com, Buchanan is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Arbutus Biopharma is a Strong Buy with an average price target of $6.33.
Karuna Therapeutics (KRTX)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Karuna Therapeutics, with a price target of $190.00. The company’s shares closed last Monday at $117.76.
According to TipRanks.com, Butler is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Karuna Therapeutics with a $181.17 average price target, which is a 54.9% upside from current levels. In a report issued on June 18, Jefferies also maintained a Buy rating on the stock with a $183.00 price target.
Arcutis Biotherapeutics (ARQT)
Mizuho Securities analyst Uy Ear reiterated a Buy rating on Arcutis Biotherapeutics yesterday and set a price target of $57.00. The company’s shares closed last Monday at $21.73.
According to TipRanks.com, Ear is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Arcutis Biotherapeutics with a $47.75 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABUS:
- Analysts Are Bullish on These Services Stocks: MGM Resorts (MGM), SKYCITY Entertainment Group Limited (SKYZF)
- Microsoft Becomes Allied Investment Advisors’ Second Biggest Bet
- JMP Securities Thinks Robinhood Markets’ Stock is Going to Recover
- Rush Street Interactive (RSI) Receives a New Rating from JMP Securities
- JMP Securities Remains a Buy on Relay Therapeutics (RLAY)